Alternative Delivery Approaches Research continues into alternative delivery routes that could improve patient convenience and expand the clinical utility of peptide therapeutics
Rodent models of neuroinflammation for Alzheimer's disease
Bombesin Receptor Subtype-3 in Human Diseases
Retrieved from Michelet, A., Mowla, M., Amo-Brown, B
Real-World Data Says Otherwise Click2Pharmacy, Mounjaro Statistics 2025 KFF, KFF Health Tracking Poll 2024: The Publics Use of GLP-1 Drugs CNN, Certain Obesity Drugs Will Cost as Little as $149 and Medicare Will Start Covering Them Under White House Deals Drugs4Delivery, Mounjaro and Wegovy Price Changes Coming September 2025 Delve Insight, 9 Promising Obesity Drugs Set To Launch by 2030 Pfizer, Pfizer to Acquire Metsera and Its Next Generation Obesity Portfolio Morning Star, Two Companies Poised to Capitalize on the Rise of GLP-1 Drugs